Biogen elects Monish Patolawala to board effective Jan 1, 2024

BIOGEN INC.

Monish Patolawala elected as director to fill a vacancy; term expires at 2024 Annual Meeting.
Patolawala qualifies as an audit committee financial expert; expected to join Audit Committee.
He will enter into standard indemnification agreement with Biogen.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Monish Patolawala

Director

BIIB · BIOGEN INC.

Effective: 2024-01-01
Filed: November 8, 2023, 6:59 PM ET

On November 6, 2023, the Board of Directors (the “Board”) of Biogen Inc. (the “Company”) elected Monish Patolawala as a director (term to expire at the 2024 Annual Meeting) to fill a vacancy, effective January 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Monish Patolawala was elected as Director at BIOGEN INC..

Action: elected
Role: Director

Exact text from the filing

On November 6, 2023, the Board of Directors (the “Board”) of Biogen Inc. (the “Company”) elected Monish Patolawala as a director (term to expire at the 2024 Annual Meeting) to fill a vacancy, effective January 1, 2024.

View on SEC.gov

BIOGEN INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-273579

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.